{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T15:37:35Z","timestamp":1726414655888},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,7]],"date-time":"2016-05-07T00:00:00Z","timestamp":1462579200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13721-016-0120-y","type":"journal-article","created":{"date-parts":[[2016,5,7]],"date-time":"2016-05-07T11:36:35Z","timestamp":1462620995000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Computational study of diarylcyclopentene derivatives as selective prostaglandin EP1 receptor antagonist: QSAR approach"],"prefix":"10.1007","volume":"5","author":[{"given":"Mukesh C.","family":"Sharma","sequence":"first","affiliation":[]},{"given":"Smita","family":"Sharma","sequence":"additional","affiliation":[]},{"given":"Shivangi","family":"Sharma","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,5,7]]},"reference":[{"key":"120_CR1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/ci990070t","volume":"42","author":"K Baumann","year":"2002","unstructured":"Baumann K (2002) an alignment-independent versatile structure descriptor for QSAR and QSPR based on the distribution of molecular features. J Chem Inf Comput Sci 42:26\u201335","journal-title":"J Chem Inf Comput Sci"},{"key":"120_CR2","doi-asserted-by":"crossref","first-page":"15792","DOI":"10.1073\/pnas.95.26.15792","volume":"95","author":"M Bhattacharya","year":"1998","unstructured":"Bhattacharya M, Peri KG, Almazan G, Ribeiro-da-Silva A, Shichi H, Durocher Y, Abramovitz M, Hou X, Varma DR, Chemtob S (1998) Nuclear localization of prostaglandin E2 receptors. Proc Natl Acad Sci USA 95:15792\u201315797","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"120_CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003495-200363001-00006","volume":"63","author":"M Bianchi","year":"2003","unstructured":"Bianchi M, Broggini MA (2003) randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee. Drugs 63(1):37\u201346","journal-title":"Drugs"},{"key":"120_CR4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0014-2999(97)01383-6","volume":"340","author":"Y Boie","year":"1997","unstructured":"Boie Y, Stocco R, Sawyer N, Slipetz DM, Ungrin MD, Neuschafer-Rube F, Puschel G, Metters KM, Abramovitz M (1997) Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol 340:227\u2013247","journal-title":"Eur J Pharmacol"},{"key":"120_CR5","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1152\/ajprenal.2000.279.1.F12","volume":"279","author":"MD Breyer","year":"2000","unstructured":"Breyer MD, Breyer RM (2000) Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol 279:F12\u2013F23","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Suppl 1","key":"120_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200363001-00002","volume":"63","author":"F Camu","year":"2003","unstructured":"Camu F, Shi L, Vanlersberghe C (2003) The role of COX-2 inhibitors in pain modulation. Drugs 63(Suppl 1):1\u20137","journal-title":"Drugs"},{"key":"120_CR7","unstructured":"Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P (1990) In comprehensive medicinal chemistry; Pergamon: Oxford, UK, vol 3, pp 643\u2013714"},{"key":"120_CR8","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","volume":"110","author":"RD Cramer","year":"1988","unstructured":"Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA) 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959\u20135967","journal-title":"J Am Chem Soc"},{"key":"120_CR9","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","volume":"294","author":"CD Funk","year":"2001","unstructured":"Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871\u20131875","journal-title":"Science"},{"key":"120_CR10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bmcl.2006.10.041","volume":"17","author":"GMP Giblin","year":"2007","unstructured":"Giblin GMP, Bit RA, Brown SH, Chaignot HM, Chowdhury A, Chessell Iain P, Clayton Nicholas M, Coleman T, Hall A, Hammond B, Hurst David N, Michel Anton D, Naylor A, Novelli R, Scoccitti T, Spalding D, Tang Sac P, Wilson Alex W, Wilson R (2007) The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)- methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain. Bioorg Med Chem Lett 17:385\u2013389","journal-title":"Bioorg Med Chem Lett"},{"key":"120_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1020869118689","volume":"16","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh A, Tropsha A (2002) Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J Comput Aided Mol Des 16:357\u2013369","journal-title":"J Comput Aided Mol Des"},{"key":"120_CR12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ejmech.2003.08.001","volume":"38","author":"SP Gupta","year":"2003","unstructured":"Gupta SP, Mathur AN, Naggapa AN, Kumar D, Kumaran S (2003) A quantitative structure-activity relationship study on a novel class of calcium entry blockers:1-[{4-(aminoalkoxy)phenylsulfonyl] indolizines. Eur J Med Chem 38:867\u2013873","journal-title":"Eur J Med Chem"},{"issue":"2","key":"120_CR13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bjp.0701367","volume":"122","author":"M Kiriyama","year":"1997","unstructured":"Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S (1997) Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 122(2):217\u2013224","journal-title":"Br J Pharmacol"},{"issue":"3","key":"120_CR14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(88)90722-4","volume":"152","author":"CA Maggi","year":"1988","unstructured":"Maggi CA, Giuliani S, Patacchini R, Conte B, Furio M, Santicioli P, Meli P, Gragnani L, Meli A (1988) The effect of SC-19220, a prostaglandin antagonist, on the micturition reflex in rats. Eur J Pharmacol 152(3):273\u2013279","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"120_CR15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1476-5381.1994.tb13139.x","volume":"112","author":"T Minami","year":"1994","unstructured":"Minami T, Nishihara I, Uda R, Ito S, Hyodo M, Hayaishi O (1994) Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice. Br J Pharmacol 112(3):735\u2013740","journal-title":"Br J Pharmacol"},{"issue":"3","key":"120_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.bjp.0704092","volume":"133","author":"T Minami","year":"2001","unstructured":"Minami T, Nakano H, Kobayashi T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Ito S (2001) Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br J Pharmacol 133(3):438\u2013444","journal-title":"Br J Pharmacol"},{"key":"120_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/365166a0","volume":"365","author":"T Namba","year":"1993","unstructured":"Namba T, Sugimoto Y, Negishi M, Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S et al (1993) Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365:166\u2013170","journal-title":"Nature"},{"issue":"4","key":"120_CR18","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","volume":"79","author":"S Narumiya","year":"1999","unstructured":"Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79(4):1193\u20131226","journal-title":"Physiol Rev"},{"issue":"4","key":"120_CR20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5155\/eurjchem.1.4.325-334.195","volume":"1","author":"BK Sharma","year":"2010","unstructured":"Sharma BK, Pilania P, Prithvi Singh P (2010) QSAR rationales for the 1,2-diarylcyclopentenes as prostaglandin EP1 receptor antagonists: potentially useful in the treatment of inflammatory pain. Euro J Chem 1(4):325\u2013334","journal-title":"Euro J Chem"},{"key":"120_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1517\/14656566.3.3.265","volume":"3","author":"CL Sheen","year":"2002","unstructured":"Sheen CL, MacDonald TM (2002) Gastrointestinal side effects of NSAIDs\u2014pharmacoeconomic implications. Exp Opin Pharmacother 3:265\u2013269","journal-title":"Exp Opin Pharmacother"},{"key":"120_CR22","first-page":"4872","volume":"63","author":"H Takeda","year":"2003","unstructured":"Takeda H, Sonoshita M, Oshima H, Sugihara K, Chulada PC, Langenbach R, Oshima M, Taketo MM (2003) Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis. Cancer Res 63:4872\u20134877","journal-title":"Cancer Res"},{"key":"120_CR19","unstructured":"VLife MDS 3.5 (2010) Molecular design suite. Vlife Sciences Technologies Pvt. Ltd., Pune. https:\/\/www.vlifesciences.com"},{"key":"120_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ddtec.2005.05.017","volume":"2","author":"A Wibberley","year":"2005","unstructured":"Wibberley A (2005) Overactive bladder: targeting prostaglandins in sensory pathways. Drug Discov Today: Therap Strateg 2:7\u201313","journal-title":"Drug Discov Today: Therap Strateg"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-016-0120-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13721-016-0120-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-016-0120-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-016-0120-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T07:51:39Z","timestamp":1567842699000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13721-016-0120-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1007\/s13721-016-0120-y","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"type":"print","value":"2192-6662"},{"type":"electronic","value":"2192-6670"}],"subject":[],"published":{"date-parts":[[2016,5,7]]},"article-number":"14"}}